Retinoblastoma–Cyclin-Dependent Kinase Pathway Deregulation in Vestibular Schwannomas

Laryngoscope

Volumn 112, Issue 9, 2002, Pages 1555-1561

  Lasak, John M ^a   Welling, D Bradley ^a   Akhmametyeva, Elena M ^a   Salloum, Mariah ^a   Chang, Long Sheng ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acoustic neuroma; DNA microarray; Immunohistochemistry; Real time polymerase chain reaction; Retinoblastoma; Retinoblastoma protein cyclin dependent kinase pathway; Vestibular schwannoma

Indexed keywords

COMPLEMENTARY DNA; CYCLIN A; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; GENE PRODUCT; NEUROFIBROMIN; PROTEIN P18; PROTEIN P19; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F4; TRNASCRIPTION FACTOR E2F5; UNCLASSIFIED DRUG;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEURILEMOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; RETINOBLASTOMA; VESTIBULAR DISORDER;

EID: 0036730785     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200209000-00004     Document Type: Article

References (30)

1. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas)
2. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2
3. A novel moesin-ezrin-radixin like gene is a candidate for the neurofibromatosis type 2 tumor suppressor
4. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion, and spreading
5. The neurofibromatoses: When less is more
6. Merlin: The neurofibromatosis 2 tumor suppressor
7. Cancer and the cell cycle
8. The Pezcoller lecture: Cancer cell cycle revisited
9. Biomedical discovery with DNA arrays
10. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
11. High through-put tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
12. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray
13. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis
14. Altered structure and expression in the human susceptibility gene in small cell lung cancer
15. Rb protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell cancer, and mesotheliomas
16. Studies of the retinoblastoma gene in human sarcomas
17. The retinoblastoma gene product in acute myeloid leukemia
18. Loss of the retinoblastoma susceptibility gene (Rb1) is a frequent and early event in prostatic tumorigenesis
19. Retinoblastoma and p53 genes as prognostic indicators in urological oncology
20. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors
21. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA
22. Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions
23. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell cancer
24. The over-expression of cyclindependent kinase (CDK) 2 in laryngeal squamous cell carcinomas
25. Overexpression of CDK2 is a prognostic indicator of oral cancer progression
26. Cell cycle control of Schwann cell proliferation: Role of cyclin-dependent kinase-2
27. p27KIPI deletions in childhood acute lymphoblastic leukemia
28. P27 in cell cycle control and cancer
29. Protective function of p27 (KIPI) against apoptosis in small cell lung cancer cells in unfavorable microenvironments
30. CDK2-dependent phosphorylation and functional inactivation of the pRb-related protein in pRb(-), p16IINK4A(+) tumor cells